97.0%
Beta blockershypertrophic obstructive cardiomyopathy (HOCM)PROSPERO
…o two retrospective cohorts with divergent findings.Conclusions Beta blockers provide consistent haemodynamic and symptomatic benefits in HOC…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
N-Acetyl Cysteine7PPIs7Streptozotocin7fondaparinux7high-dose corticosteroids7hydroxyurea7naltrexone7tyrosine kinase inhibitors7vaccines7SGLT-2i6Glipizide6BLV6Varenicline6Camrelizumab6Cancer Drugs6Benzene6Doxy-PEP6SGLT-2is6Aprepitant6DEX6Dostarlimab6T-DXd6Azacitidine6Esketamine6NAC6Fidaxomicin6ITM6Minocycline6N-acetylcysteine6pMDIs6NBCA6Clofazimine6Filgotinib6Ravulizumab6Atomoxetine6Methylphenidate6amoxicillin-clavulanate6Acetylcysteine6Triamcinolone6anti-PD16Nitrous oxide6Octreotide6injectate6IL-1β6Lenalidomide6OAC6Venetoclax6antihypertensive drugs6n-BCA6Anti-TNF6Golimumab6Placebo6aripiprazole6b/tsDMARDs6Lansoprazole6MDPV6Mitomycin C6Nalbuphine6PCSK9 inhibitors6Sodium-Glucose Co-Transporter 2 Inhibitors6
Articles mentioning drugs
10,506 articles · page 455 of 876natalizumabocrelizumabrituximabmultiple sclerosisMShigh-efficacy therapymonoclonal antibodies
… were identified in three MS registries. Patients who commenced natalizumab, ocrelizumab, or rituximab between ages 12–17 into the early tr…
tocilizumabcyclophosphamidedual antiplateletsGCAintracranial vasculitisintracranial giant cell arteritis
…ulitis. Recurrent infarcts occurred despite high-dose steroids, tocilizumab, cyclophosphamide and dual antiplatelets. Acute deterioration n…
JIB04pancreatic ductal adenocarcinoma (PDAC)anti-PD-1 therapyimmunotherapyanti-programmed cell death protein-1 (PD-1) therapy
…ough screening, we identified the histone demethylase inhibitor JIB04, which synergized with anti-PD-1 therapy to enhance T cell cyto…
antiplateletsanticoagulantsantithromboticsCRCantithrombotic therapycolorectal cancerdiverticulosis
…ivity threshold was 75 ng/mL. Patients were grouped by therapy: antiplatelets (n=1904), anticoagulants (n=262) or no antithrombotic treatment…
EltrombopagccRCCclear cell renal cell carcinoma (ccRCC)
…metabolomics. Virtual screening identified the TRIM28 inhibitor Eltrombopag, which was tested in combination with anti-programmed cell deat…
atorvastatinmetforminlinagliptinosteoporosistype 2 diabeteshyperlipidaemia
…etes and hyperlipidaemia, and takes metformin, linagliptin, and atorvastatin. She does not smoke or drink alcohol. She reports reaching meno…
tranexamic acidterlipressinpotassium competitive acid blockersAUGIBAcute upper gastrointestinal bleeding
…mboelastography-guided correction of coagulopathy, avoidance of tranexamic acid and quality of care initiatives focused on resuscitative manage…
arsenic trioxideall-trans retinoic acidposaconazoleacute promyelocytic leukaemiadiabetes
…ago, he underwent chemotherapy with all-trans retinoic acid and arsenic trioxide and received prophylactic posaconazole 300 mg orally every day …
faricimabBellberry LimitednAMDAnti-vascular endothelial growth factor therapySinghealth Centralized Institutional Review Boardneovascular age-related macular degenerationSt Vincent’s Hospital Human Research Ethics Committee
… patients currently treated for nAMD who switch to intravitreal faricimab therapy under a treat-and-extend regimen.Methods and analysis T…
Ionising radiationlung cancermelanomaprostate cancersolid cancers
…Objectives Ionising radiation is a human carcinogen; however, there are uncertainties about t…
88.7%
d-dimerPulmonary embolism (PE)multimodal quality interventionPE
…ervention to reduce excess CTPA studies and increase the use of d-dimer assays prior to CTPA. Balance measures included the rate of pos…